JP2016529489A5 - - Google Patents

Download PDF

Info

Publication number
JP2016529489A5
JP2016529489A5 JP2016525805A JP2016525805A JP2016529489A5 JP 2016529489 A5 JP2016529489 A5 JP 2016529489A5 JP 2016525805 A JP2016525805 A JP 2016525805A JP 2016525805 A JP2016525805 A JP 2016525805A JP 2016529489 A5 JP2016529489 A5 JP 2016529489A5
Authority
JP
Japan
Prior art keywords
polypeptide
buffer
contaminants
gradient
chromatography material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016525805A
Other languages
English (en)
Japanese (ja)
Other versions
JP6462681B2 (ja
JP2016529489A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/046338 external-priority patent/WO2015006686A1/en
Publication of JP2016529489A publication Critical patent/JP2016529489A/ja
Publication of JP2016529489A5 publication Critical patent/JP2016529489A5/ja
Application granted granted Critical
Publication of JP6462681B2 publication Critical patent/JP6462681B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016525805A 2013-07-12 2014-07-11 イオン交換クロマトグラフィーのインプットの最適化の解明 Active JP6462681B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361845890P 2013-07-12 2013-07-12
US61/845,890 2013-07-12
PCT/US2014/046338 WO2015006686A1 (en) 2013-07-12 2014-07-11 Elucidation of ion exchange chromatography input optimization

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018242206A Division JP2019090818A (ja) 2013-07-12 2018-12-26 イオン交換クロマトグラフィーのインプットの最適化の解明

Publications (3)

Publication Number Publication Date
JP2016529489A JP2016529489A (ja) 2016-09-23
JP2016529489A5 true JP2016529489A5 (enExample) 2017-08-31
JP6462681B2 JP6462681B2 (ja) 2019-01-30

Family

ID=51257626

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016525805A Active JP6462681B2 (ja) 2013-07-12 2014-07-11 イオン交換クロマトグラフィーのインプットの最適化の解明
JP2018242206A Pending JP2019090818A (ja) 2013-07-12 2018-12-26 イオン交換クロマトグラフィーのインプットの最適化の解明

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018242206A Pending JP2019090818A (ja) 2013-07-12 2018-12-26 イオン交換クロマトグラフィーのインプットの最適化の解明

Country Status (18)

Country Link
US (2) US10274466B2 (enExample)
EP (2) EP3536699A1 (enExample)
JP (2) JP6462681B2 (enExample)
KR (1) KR102251127B1 (enExample)
CN (1) CN105377873B (enExample)
AU (1) AU2014287044B2 (enExample)
BR (1) BR112016000231A8 (enExample)
CA (1) CA2918052A1 (enExample)
ES (1) ES2705700T3 (enExample)
HR (1) HRP20190071T1 (enExample)
IL (1) IL243305B (enExample)
MX (1) MX368107B (enExample)
PL (1) PL3019516T3 (enExample)
RU (1) RU2016104542A (enExample)
SG (1) SG11201600221YA (enExample)
SI (1) SI3019516T1 (enExample)
TR (1) TR201818966T4 (enExample)
WO (1) WO2015006686A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2705700T3 (es) 2013-07-12 2019-03-26 Hoffmann La Roche Elucidación de la optimización de entrada en cromatografía de intercambio iónico
CN107110835B (zh) 2014-11-12 2019-07-26 通用电气健康护理生物科学股份公司 用于确定实验参数对液相色谱协议的影响的方法和系统
GB2539420B (en) * 2015-06-16 2021-01-13 Cytiva Sweden Ab Determination of chromatography conditions
BR112020019882A2 (pt) * 2018-04-02 2021-01-05 Amgen Inc. Composições de erenumabe e seus usos
JP2021530247A (ja) * 2018-07-05 2021-11-11 オベーション ダイアグノスティクス エルエルシー 癌の診断のためのBCl−2抗体とイムノアッセイ
KR20200080748A (ko) * 2018-12-27 2020-07-07 주식회사 폴루스 음이온 교환 크로마토그래피를 이용한 인슐린 전구체의 정제방법
WO2024261724A1 (en) * 2023-06-23 2024-12-26 Lupin Limited Ion-exchange chromatography for separation and analysis of charge variants

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4666855A (en) * 1985-07-31 1987-05-19 Massachusetts Institute Of Technology Rapid method for determining the isoelectric point for amphoteric molecules
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
ES2037273T3 (es) 1987-04-11 1993-06-16 Ciba-Geigy Ag Proceso de focalizacion isoelectrica y medios para llevar a cabo dicho proceso.
DE3850542T2 (de) 1987-09-23 1994-11-24 Bristol Myers Squibb Co Antikörper-Heterokonjugate zur Töting von HIV-infizierten Zellen.
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
ATE144793T1 (de) 1989-06-29 1996-11-15 Medarex Inc Bispezifische reagenzien für die aids-therapie
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
US5229275A (en) 1990-04-26 1993-07-20 Akzo N.V. In-vitro method for producing antigen-specific human monoclonal antibodies
JPH06500011A (ja) 1990-06-29 1994-01-06 ラージ スケール バイオロジー コーポレイション 形質転換された微生物によるメラニンの製造
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
WO1992020373A1 (en) 1991-05-14 1992-11-26 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
MX9204374A (es) 1991-07-25 1993-03-01 Idec Pharma Corp Anticuerpo recombinante y metodo para su produccion.
WO1993006217A1 (en) 1991-09-19 1993-04-01 Genentech, Inc. EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab')2 ANTIBODIES
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
FI941572L (fi) 1991-10-07 1994-05-27 Oncologix Inc Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
AU3178993A (en) 1991-11-25 1993-06-28 Enzon, Inc. Multivalent antigen-binding proteins
ATE419355T1 (de) 1992-02-06 2009-01-15 Novartis Vaccines & Diagnostic Marker für krebs und biosynthetisches bindeprotein dafür
EP0626012B1 (en) 1992-02-11 2003-07-09 Cell Genesys, Inc. Homogenotization of gene-targeting events
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
ATE149570T1 (de) 1992-08-17 1997-03-15 Genentech Inc Bispezifische immunoadhesine
ES2091684T3 (es) 1992-11-13 1996-11-01 Idec Pharma Corp Aplicacion terapeutica de anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de las celulas b.
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5712374A (en) 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
ATE321066T1 (de) 1998-05-06 2006-04-15 Genentech Inc Anti-her2 antikörperzusammensetzung
SE9803838D0 (sv) * 1998-11-09 1998-11-09 Knut Irgum A chromatography method and a column material useful in said method
IL127127A0 (en) 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
US6451987B1 (en) * 1999-03-15 2002-09-17 Novo Nordisk A/S Ion exchange chromatography of proteins and peptides
DE60017888T2 (de) 1999-04-05 2006-01-19 Emisphere Technologies, Inc. Dinatrium-salze, monohydrate und ethanol-solvate
US8372954B2 (en) 2000-12-22 2013-02-12 National Research Council Of Canada Phage display libraries of human VH fragments
JP2005289809A (ja) 2001-10-24 2005-10-20 Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) 突然変異重鎖抗体
AU2003265994B2 (en) 2002-09-11 2010-04-01 Genentech, Inc. Protein purification
WO2004103519A2 (en) 2003-05-16 2004-12-02 Cryobiophysica, Inc. External gradient chromatofocusing
DK1639011T3 (da) 2003-06-30 2009-02-16 Domantis Ltd Pegylerede enkelt-domæne antistoffer (dAb)
US7906630B2 (en) 2004-04-27 2011-03-15 PerkinElmer Heath Sciences, Inc. Method for identifying peptides in a biological sample
EP1756852B1 (en) 2004-05-20 2014-04-30 Waters Technologies Corporation Method and apparatus for identifying proteins in mixtures
CA2583081A1 (en) 2004-06-16 2006-01-19 Bio-Rad Laboratories, Inc. Multichemistry fractionation
WO2006031370A2 (en) 2004-08-19 2006-03-23 Genentech, Inc. Polypeptide variants with altered effector function
WO2006024497A1 (en) * 2004-08-30 2006-03-09 Lonza Biologics Plc. Affinity- plus ion exchange- chromatography for purifying antibodies
ES2579805T3 (es) 2004-09-23 2016-08-16 Genentech, Inc. Anticuerpos y conjugados modificados por ingeniería genética con cisteína
JP2006087394A (ja) * 2004-09-27 2006-04-06 Wako Pure Chem Ind Ltd 核酸抽出方法および核酸抽出キット
GB0613753D0 (en) 2006-07-11 2006-08-23 Norwegian Radium Hospital Res Method
JP2010089001A (ja) * 2008-10-07 2010-04-22 Japan Organo Co Ltd クロマト分離方法
CA2754528A1 (en) 2009-03-06 2010-09-10 Genetech, Inc. Antibody formulation
WO2011009623A1 (en) * 2009-07-24 2011-01-27 F. Hoffmann-La Roche Ag Optimizing the production of antibodies
CA2772653C (en) * 2009-09-01 2019-06-25 Genentech, Inc. Enhanced protein purification through a modified protein a elution
US9278297B2 (en) * 2010-07-09 2016-03-08 Ge Healthcare Bio-Sciences Ab Method for ion-exchange chromatography and media used thereof
WO2012102104A1 (ja) 2011-01-24 2012-08-02 シャープ株式会社 露光装置、液晶表示装置及びその製造方法
JP2014510734A (ja) 2011-03-31 2014-05-01 アポテックス テクノロジーズ インコーポレイテッド D−ガンマ−グルタミル−d−トリプトファンおよびd−ガンマ−グルタミル−l−トリプトファンのプロドラッグ
WO2014078729A1 (en) 2012-11-15 2014-05-22 Genentech, Inc. IONIC STRENGTH-MEDIATED pH GRADIENT ION EXCHANGE CHROMATOGRAPHY
ES2705700T3 (es) 2013-07-12 2019-03-26 Hoffmann La Roche Elucidación de la optimización de entrada en cromatografía de intercambio iónico

Similar Documents

Publication Publication Date Title
JP2016529489A5 (enExample)
JP2015537212A5 (enExample)
RU2015122726A (ru) ОПОСРЕДОВАННАЯ ИОННОЙ СИЛОЙ рН-ГРАДИЕНТНАЯ ИОНООБМЕННАЯ ХРОМАТОГРАФИЯ
RU2016104542A (ru) Осуществление оптимизации входных условий ионообменной хроматографии
ES2826123T3 (es) Método de purificación de anticuerpos
WO2015038884A3 (en) Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products
CA3031469C (en) Methods of purifying fc-containing proteins
Wolfe et al. Multimodal chromatography: characterization of protein binding and selectivity enhancement through mobile phase modulators
EP2969098B1 (en) Methods for purifying antibodies
WO2015195453A3 (en) Methods for increasing the capacity of flow-through processes
EA201691811A1 (ru) Варианты гфпд и способы их применения
EA201990321A1 (ru) Биспецифические антителоподобные связывающие белки, которые специфически связываются с cd3 и cd123
HRP20192217T1 (hr) ULTRA-PROČIŠĆENI DsbA I DsbC TE POSTUPCI NJIHOVE IZRADE I UPORABE
JP2018510867A5 (enExample)
JP2015503524A5 (enExample)
EA201592192A1 (ru) Способ очистки моноклональных антител
US10370408B2 (en) Method for purification of a DNase or RNase protein from a sample
RU2013156669A (ru) Промывочный раствор и способ аффинной хроматографии
JP2018516229A5 (enExample)
RU2018121657A (ru) ПРОТИВОПОЛОЖНЫЕ ГРАДИЕНТЫ pH-СОЛЬ ДЛЯ УЛУЧШЕННОГО РАЗДЕЛЕНИЯ БЕЛКОВ
RU2014111820A (ru) Способы элиминации вируса
JP2016508503A5 (enExample)
RU2018121653A (ru) Улучшенное разделение белков при ионообменной хроматографии
Marek et al. Isolation of monoclonal antibody from a Chinese hamster ovary supernatant. I: Assessment of different separation concepts
Kröner et al. Analytical characterization of complex, biotechnological feedstocks by pH gradient ion exchange chromatography for purification process development